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doi:10.1016/j.ejvs.2010.04.021Abstract Objective: The objective of this study was to externally validate the existing
Australian Endovascular aneurysm repair Risk Assessment (ERA) Model using data from a major
vascular centre in the United Kingdom.
Methods: Data collected from 312 endovascular abdominal aortic aneurysm repair patients at
St George’s Vascular Institute, London, UK were fitted to the ERA Model.
Results: Despite St George’s patients being sicker (p < 0.001), having larger aneurysms
(p < 0.001) and being more likely to die (p < 0.05) than the Australian patients, their data
fitted the ERA Model well for the risk factors early death, aneurysm-related death, three-year
survival and type I endoleaks as evidenced by higher area under ROC curves and/or higher R2
goodness of fit statistics than the Australian data.
Conclusions: The first external validation of the ERA Model using data from St George’s
Vascular Institute suggests that this tool can be used in different countries and hospital
settings. The authors believe the ERA Model is robust and allows valid personalised predictions
of outcomes by surgeons treating routine aneurysms as well as those in tertiary referral prac-
tices with more adverse outcomes.
ª 2010 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.Introduction
The Endovascular aneurysm repair Risk Assessment (ERA)
Model was developed in 2007 using data obtained from an8222 7711; fax: þ61 8 8222 6028
e.edu.au (R.A. Fitridge).
lsevier Ltd on behalf of EuropeanAustralian audit of endovascular aortic aneurysm repair
(EVAR).1 The audit followed the outcomes for 961 patients
who underwent elective or semi-urgent repair between
1999 and 2001 for a minimum of five years. The ERA Model is.
Society for Vascular Surgery.
Validation of ERA Model 437available at the following website (www.health.adelaide.
edu.au/surgery/evar); the user interface is shown in
Fig. 1. Individual scenarios for patients are included in the
2008 paper by Barnes et al.1
The ERA Model enables clinicians to enter up to eight pre-
operative variables for a patient, in order to derive the pre-
dicted likelihood of primary endpoints such as early death,
aneurysm-related death, survival, type I endoleaks and mid-
term re-interventions. Secondary endpoints include technical
and clinical success, type II endoleaks, graft complications,
migration, rupture and conversion to open repair.
Information pertaining to the Australian audit of EVAR
has been published previously.2,3 These articles describe
the predictors of success following EVAR (ASA, age, aneu-
rysm size, creatinine, neck angulation and infra-renal neck)
that were found to best predict early and mid-tem
outcomes and were therefore included in the ERA Model.
We described the development of the ERA Model in our
2008 paper.1 Generalised linear regressions with the ‘logit’
link (logistic regressions) were used to determine which of
the eight pre-operative variables should be included in the
ERA Model for each endpoint. Survival analysis could have
been used for some endpoints (e.g. aneurysm-related death
and survival) as shown previously.2 However endpoints such
as conversion to open repair and early death are not
amenable to survival methods. Hence, for reasons of
simplicity logistic regression was the only method used for
the ERA Model. Percentage estimates of three and five year
survival are readily interpretable by surgeons and patients.
Some outcomes shown in the ERA Model have relatively
wide confidence intervals (CIs). This is not surprising as these
CIs are based on the range of outcomes for a similar group of
patients in the original Australian audit. Hence, CIs provide
additional information for surgeons and their patients intoFigure 1 ERA Modethe possible variation that can occur and which may help
them decide whether or not to proceed with the EVAR.
Wepreviously described internally validating theERAModel
using bootstrapping.1 Bootstrapping is a model validation
technique which resamples from the data at hand.4 Here we
describe externally validating the model using data pertaining
to 312 patients who underwent EVAR at St George’s Vascular
Institute, London, UK, between April 2001 and March 2007.
According to a recent systematic review by Chambers et
al. the ERA model is currently the only risk modelling study
to have developed risk algorithms ‘from scratch’ and the
review concluded that along with three other studies
developed using existing risk algorithms it appears to be
‘potentially the most useful for clinical decision-making’.5
Their review of risk modelling studies also reported
a general lack of validated quality assessment tools. Hence,
one purpose of this paper is to further demonstrate the
validity of the ERA Model with external data.
Methods
De-identified data for 312 EVAR patients who underwent
procedures between April 2001 and March 2007 at St
George’s Vascular Institute, London, UK, were provided in
Excel spreadsheet format. The data were mapped and
checked to ensure all required fields corresponded with
those used in the ERA Model.
Pre-operative variables
The model determines the likely outcome following surgery
basedonfive readilyavailablepre-operative variables (ageat
operation in years), American Society of Anaesthesiologistsl user interface.
438 M. Barnes et al.(ASA) rating (IeV), gender, aneurysm diameter (mm) and
creatinine (mmol/L). The input of three additional post-
imaging variables further helps to refine the results; aortic
neckangle (degrees), infra-renal neck length (mm)and infra-
renal neck diameter (mm).
The regions of applicability used for the ERA Model (i.e.
the region within which most of the Australian data fell
where the model is reliable) are as follows: age (55e90
years), ASA (IeIV), maximum aneurysm diameter
(40e80 mm), creatinine (60e200 mmol/L), infra-renal neck
length (6e45 mm), infra-renal neck diameter (17e32 mm).
Where an individual’s results exceed any of these values
the nearest limit applies.
Table 1 shows which pre-operative variables were
included in each of the outcome models. Blank cells denote
non-inclusion. Cells listing p-values indicate inclusion. For
example, aneurysm diameter, age, ASA, and creatinine
were all used for the 3-year survival outcome model.
The inclusion criteria used was Akaike’s Information
Criterion (AIC). AIC estimates the goodness of fit of
a model. The reduction in AIC compares the fit with and
without each term included.6 p-values are displayed
because they are more readily understood than a reduction
in AIC. They are likelihood ratio p-values.1,7,8 Even though
some p-values are greater than the traditional cut-off of
0.05, the reduction in AIC was significant, and therefore
were included in the model.
All eight of the pre-operative variables used in the ERA
Model had been collected at St George’s.
Missing data for pre-operative variables were dealt
with as follows. Two patients with missing pre-operative
aneurysm diameter measurements were omitted. 18
missing ASA values were assumed to be the most common
ASA of III (48% St George’s EVAR patients had ASA III,
Table 2). Postoperative infra-renal neck diameters and
length were used where pre-operative was missing in two
& three cases respectively. Hence, data for 310/312
patients were used.
Postoperative outcomes
Data for early death (i.e. death within 30 days of the
original procedure) was readily available. Aneurysm-
related deaths included early deaths, deaths within 30 days
of an aneurysm-related procedure and deaths due toTable 1 Pre-operative variables used to develop each original
Pre-operative variable
Outcome
Aneurysm
Diam.
Age ASA Ge
3-Year survival <0.001 <0.001 <0.001
Aneurysm-related death <0.001 0.030
Early death 0.001 0.070
Initial re-interventions 0.057
Mid-term re-interventions 0.0
Initial endoleak type I
Mid-term endoleak type I 0.005
Initial endoleak type II 0.074 0.0
Mid-term endoleak type II 0.110 0.0aneurysm rupture. Due to the recency of much of the St
George’s data, only around half could be used to assess
3-year survival (n Z 144). Deaths were reported up to 18
May 2008; therefore only patients with procedures before
19 May 2005 were used to validate 3-year survival.
Data for type I & II endoleaks were assessed as follows:
initial endoleaks were those documented from day 1 to day
30; mid-term endoleaks were those occurring after day 30.
Initial re-interventions were those performed on the
same day or within 30 days of the EVAR procedure and mid-
term interventions were those performed more than 30
days after the initial procedure.
Some outcome measures that were originally included
from the Australian dataset could not be assessed for St
George’s data. The recency of the data meant that five-year
survival data was not available; only 144/310 patients had
sufficiently long follow up to be included in the 3-year survival
analysis. There were too few migrations (7/310) and conver-
sions to open repair (0) to assess the model. Graft complica-
tions, clinical and technical success were not available.
External validation
Predictions were made using the St George’s data predictor
variables and the Australian ERA Model coefficients. The
goodness of fit of these models was assessed using Frank
Harrell’s Design package.9 Specifically, the val.prob func-
tion was used to compare the predicted values for St
George’s data with the actual observed outcomes. The
goodness of fit of St George’s outcomes was assessed using
the following statistics.
 The area under the receiver operating characteristic
(ROC) curve,
 R2, specifically Nagelkerke-Cox-Snell-Maddala-Magee R2
statistic,
Predictions conducted in the S-plus package did not
make use of the region of applicability adjustments.
Predictions were made for the actual value of each
predictor for each patient. For example when the maximum
aneurysm diameter was very high, the actual diameter was
used for predictions, rather than using the ninety-fifth
percentile of the Australian data (top applicability limit).
Eleven percent of UK data was higher than the upper limit
of Australian region of applicability.outcome model (p-values).
nder Creatinine Aortic
neck angle
infra-renal
neck diam.
infra-renal
neck length
0.002
45 0.029 0.014
0.007
0.130
21
88
Table 2 Predictor variables: St George data compared to Australian data.
St George’s data Australian data p-Value
Male ratio 90% 86%
Mean age 77.4  7.8 75  6.9 years <0.001
ASA I 0% 3% 0.79
ASA II 24% 32% 0.007
ASA III 48% 59% <0.001
ASA IV 27% 6% <0.001
Mean aneurysm sizea 64 mm 58 mm <0.001
Aneurysms <55 mm 19% 44% <0.001
Mean creatinine (mmol/L) 118 115 0.48
Creatinine <120 (normal) 70% 67%
Mid (120e150) 18% 21%
High (>160) 11% 12%
Mean infra-renal neck length 23.7 mm 25.7 mm 0.018
20 54% 25% <0.001
>20 46% 75% <0.001
infra-renal neck diameter (mm) 23.7 23.6 0.70
Aortic neck angle 45 30% 15.6% <0.001
a Eleven percent of the St George’s data for maximum aneurysm diameter was above the region of applicability limit of 80 mm used in
the ERA Model.
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Comparison of St George’s Vascular Institute and
Australian data
Tables 2 and 3 provide a comparison of rates for data from St
George’s and the Australian audit. The following are worth
noting. There were considerably more perioperative (early)
deaths in the St George’s data, 4.2% as compared to 1.8%
Australian perioperative deaths (p Z 0.003). There were
considerably more aneurysm-related deaths in the St
George’s data, 4.8% as compared to 2.6% Australian deaths
(pZ 0.03). St George’s patients were less likely to survive 3
years than Australians; 69% compared to 81% (p < 0.001). St
George’s patients more often required initial interventions;
41% compared to 32% (p < 0.001). Fewer of the EVAR
procedures at St George’s were performed on small aneu-
rysms (<55 mm); 19% compared with 44% (p < 0.001) and
conversely. EVAR procedures at St George’s were performedTable 3 Outcome rates: St George’s data compared to Australi
St George’s dataa % (n
Perioperative (early) death 4.2% (13)
Aneurysm-related death 4.8% (15)
3-Year survival 69.4% (100/144)
Endoleaks
Initial Type-1 3.2% (10)
Initial Type-2 4.8% (15)
Mid-term Type-1 3.2% (10)
Mid-term Type-2 9.7% (30)
Initial interventions 41% (126)
Mid-term interventions 11.3% (35)
Bolding indicates significance at the 0.05 level.
a St George’s rates are usually out of 310 patients. Three-year surv
years before survival data collected.on larger aneurysms; UK average 64 mm compared with
58mm in Australia (p< 0.001). Sicker patients, as evidenced
by an ASA rating of IV had the EVAR procedure at St George’s
(27%) compared with 6% in Australia (6%) (p < 0.001). Aortic
neck angles in the St George’s data were more often 45
degrees; 30% compared with 15.6% (p < 0.001). St George’s
neck lengths were generally shorter; 54% 20mm compared
to 25% (p < 0.001).
Goodness of fit
Some of the assessments of goodness of fit are shown in
Table 4. The table compares the fit of the St George’s data
with the Australian models. Generally there was not a large
difference in fit between the St George’s and Australian
data as shown by the small differences in areas under the
ROC curves in Fig. 2.
St George’s patients as a whole were sicker (p < 0.001),
had larger aneurysms (p < 0.001), more difficult anatomyan data.
) Australian data % (n) p-Value
1.8% (17) 0.003
2.6% (25) 0.03
80.7% (774/959) <0.001
2.9% (28) 0.12
7.0% (67) 0.05
4% (36) 0.118
12% (111) 0.055
32% (262) <0.001
11.6% (109) 0.07
ival only included 144 patients who had their EVARs more than 3
Table 4 Goodness of fit for St George’s Vascular Institute and Australian data.
Early
death
Aneurysm-
related
death
mid-term
interv.
Initial
endoleak
type I
mid-term
endoleak
type I
Survival
3 year
Initial
endoleak
type II
mid-term
endoleak
type II
Initial interv.
St George’s Vascular Institute
c ROC 0.80 0.83 0.51 0.57 0.73 0.70 0.53 0.49 0.52
R2 0.111 0.132 0.003 0.001 0.061 0.132 0.002 0.000 0.002
Australian data
c ROC 0.71 0.75 0.60 0.64 0.64 0.71 0.59 0.54 0.54
R2 0.075 0.110 0.029 0.049 0.049 0.128 0.030 0.009 0.005
Interv Z intervention.
Where: c ROC is the Area under ROC curve. A ROC value approaching 1 suggests a better model than those close to 0.5.
R2 index.
The higher the R2 the better the model fit.
Bolding indicates higher goodness of fit values for St George’s data than the Australian data.
Figure 2 Area under ROC curve for nine outcomes: St
George’s and Australian fit. A ROC value approaching 1 suggests
a better model than those close to 0.5.
440 M. Barnes et al.(shorter and more angulated necks, p < 0.001), and were
more likely to die (p < 0.05) than the Australian patients.
However, the ERA Model provided a comparable fit for the
St George’s patient outcomes of early death, aneurysm-
related death, 3-year survival and mid-term type I endo-
leaks than for the Australian data as evidenced by higher
area under ROC curves and/or higher R2 goodness of fit
statistics (shown by bolding in Table 4).
That the ERA Model performed well on predictions of
perioperative and aneurysm-related death and 3-year
survival is highly relevant as these are clearly important
endpoints. The models estimating the likelihood of
requiring an additional intervention or having type II
endoleaks did not perform as well, with low ROC area and
low R2, indicating room for improvement for these two
outcomes.
Discussion
The ERA Model is simple for surgeons and patients to use as
it only requires 8 pre-operative variables to be entered. We
believe that by keeping the model simple its accessibility is
increased. For the ERA Model to be useful it was necessary
to validate it with external data. We have presented here
the results of validating the model with data supplied from
a leading specialist vascular centre in the UK, the St
George’s Vascular Institute. Previously the model had been
internally validated, and could only be used confidently
within the Australian context. Whilst further ongoing vali-
dation is planned, it is pleasing that the new data presented
a good fit, on a number of important outcomes. Three-year
survival achieved a very comparable fit to the Australian
data, even though only half the cohort was available. The
similar R2 and ROCs indicate it is likely that this goodness of
fit will remain as more data is gathered.
As seen in Table 2, there are significant differences
between the population of patients who undergo EVAR in
Australia and those who do so at St George’s. The results
show that sicker patients with larger aneurysms and more
difficult anatomy are managed at St George’s Vascular
Institute. This may partly reflect the tertiary referral
nature of this Institute’s practice. The model allows per-
sonalised predictions for these disparate data sets andvalidates the higher incidence of adverse outcomes in the
St George’s data set. Such an approach allows valid
predictions of outcomes in units by surgeons treating
routine aneurysms and those in tertiary referral practices
who would be expected to have more adverse outcomes
due to treating more complex aortic aneurysms.
Despite the differences between the two populations
the ERA Model fit for early death, aneurysm-related death,
3-year survival and mid-term type I endoleaks for St
George’s patients was comparable to that of Australian
patients. This suggests that the ERA Model is robust, in the
sense that it has been validated for a different population
of patients in the UK and appears to be relevant beyond the
region of applicability of the Australian data for the key
outcomes of early death, aneurysm-related death, 3-year
survival and mid-term type I endoleaks.
Not all outcomes were available in the St George’s data.
Outcomes that were tested but performed less well were
initial type I endoleaks, type II endoleaks and re-interven-
tions. Interestingly, apart from initial type-1 endoleaks,
these outcomes were not as strong a fit in terms of area
under the ROC curve or R2 as the other outcomes for the
Australian data, and in each case less so for the UK data.
Whilst type II endoleaks are not as clinically important as
those pertaining to survival, the need to undergo
Validation of ERA Model 441subsequent procedures for an abdominal aortic aneurysm,
especially in the perioperative period, is clearly a major
consideration for a patient and associated with significant
complications.
The data on which the ERA Model is based (and tested
here) may have some bearing on type I endoleaks as the
procedures used older graft technology. The advent of
newer endografts may influence the technical success of
endografting and potentially impact on outcomes and
incidence of endoleaks. Hence, type I endoleaks and early
re-interventions will need to come under close scrutiny as
part of our new study into graft outcomes as they are likely
to be subject to model drift.
Some outcomes performed poorly indicating room for
improvement. Additional interventions and type II endo-
leaks had low ROC area and low R2. During the next five
years substantial work will be put into testing and
improving the model based on new data from Australia and
the UK. Survival techniques and more complex relationships
may be included. Predictor variables other than the eight
used currently may significantly improve the ability to
predict these outcomes.
The aim of developing the ERA Model was to provide
a useful tool for surgeons and patients to help with deci-
sion-making and risk assessment. Even though EVARs are
now performed routinely, they are not always the best
alternative for an individual patient. If the risk of graft
complications is high then it may be more appropriate to
perform an open aneurysm repair (or possibly fenestrated
repair). The model will also help quantify perioperative
mortality and mid-term survival in individuals with signifi-
cant co-morbidities who may be most appropriately
managed without intervention.
Generalised statistical outcomes are not always help-
ful when making individual decisions, and although clin-
ical experience is paramount, being able to back this up
with a robust model is helpful. Validating the model
internally and now externally are the first steps towards
ensuring the model is robust. Our aim over the next five
years is to test the model with new Australian data
(>1000 patients) and other large external datasets to see
if it can be improved and to determine whether new and
upgraded stent-grafts have had an impact on patient
outcomes. We also aim to continue testing and developing
the model using external data during this time to assess
how well the ERA Model behaves with data from different
populations.Conflict of Interest
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